Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
FDA approves GSK’s vaccine Arexvy against respiratory syncytial virus (RSV) for older people. Plus, prehistoric pendant’s DNA reveals the person who held it and investment in diseases that mostly affect women could reap big rewards.
The most popular repository for sharing SARS-CoV-2 sequence data has come under increasing scrutiny. Scientists and funders around the world must now consider what lies ahead for the open sharing of genome data.
Results suggest that the amyloid-targeting drug candidate slows cognitive decline in some people, but questions remain over its potential side effects.